Profitelligence Profitelligence · Filing Ledger Open MDT research →

Form 8-K · Current Report · Filed 2025-09-29

Medtronic PLC Announces Issuance of Senior Notes and Redemption of Outstanding Notes

On September 29, 2025, Medtronic PLC, through its subsidiary Medtronic, Inc., issued €1.5 billion aggregate principal amount of senior notes due 2030 and 2045, and Medtronic Luxco redeemed all €500 million of its outstanding 2.625% Senior Notes due 2025.

Filer
Medtronic plc MDT · NYSE
Filed
Accession
0001193125-25-221819
CIK
0001613103
Signal
High impactHealthcare

Details

The new notes will be used to repay existing senior notes.

Items reported

Item 1.01

Entry into a Material Definitive Agreement

New Major Contract New Major Contract
Item 8.01

Other Events

Regulatory Approval
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$94.22

Next session

+1.1%

Since filing

-9.4%

Latest close

$85.39

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from MDT reporting the same item, with the next session's move:

About Medtronic plc

Medtronic plc is a leading global healthcare technology company that designs, manufactures, and sells innovative medical devices and therapies used in various medical procedures. The primary function of Medtronic is to improve healthcare outcomes by providing advanced therapeutic solutions. Its extensive product portfolio includes cardiac and vascular devices, diabetes-related products, minimally invasive therapies, and neurosurgical technologies. Medtronic plays a vital role in the medical device industry, catering to cardiovascular treatment, advanced diabetes management, spinal and musculoskeletal therapy, and more. Notably, the company is renowned for its pacemaker technology and is a pivotal player in cardiac care. The company's innovations significantly impact the healthcare sector by enhancing the quality of life for patients worldwide and improving the effectiveness of medical treatments. As a key player in the medical device market, Medtronic is instrumental in setting industry standards and advancing medical technology through continuous research and development. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic's global presence underscores its substantial contribution to the healthcare industry across various continents.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another MDT filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts